title: Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.
authors.affiliation: Henan Tumor Hospital, Henan Institute of Hematology, Henan Medical School, Henan University, Zhengzhou, China.
authors.forename: Baijun
authors.initials: B
authors.lastname: Fang
authors.forename: Yongping
authors.initials: Y
authors.lastname: Song
authors.forename: Jie
authors.initials: J
authors.lastname: Ma
authors.forename: Robert C
authors.initials: RC
authors.lastname: Zhao
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000209:etiology*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone